Vir Biotechnology, Inc. · NASDAQ:VIR
Sb Investment Advisers (UK) LTD reported a 9.40% stake in Vir Biotechnology, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Sb Investment Advisers (UK) LTD reported a 9.40% stake in Vir Biotechnology, Inc., 13,116,977 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 13,116,977
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SB Investment Advisers (UK) Limited | 9.40% | 13,116,977 |
| SoftBank Vision Fund (AIV M1) L.P. | 9.40% | 13,116,977 |
| SVF Endurance (Cayman) Limited | 9.40% | 13,116,977 |
Source
Related
- Vir Biotechnology, Inc.
- Sb Investment Advisers (UK) LTD
- Vir Biotechnology, Inc. shareholders
- Schedule 13G/A · Sb Investment Advisers (UK) LTD · May 15, 2026
- Form 4 · More Robert J · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · Coughlin Timothy · Jun 10, 2026
- Form 4 · Napolitano Janet · Jun 2, 2026